Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dysthyroid Ophthalmopathies”

185 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 185 results

Not applicableStudy completedNCT02397109
What this trial is testing

MDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)

Who this might be right for
Dysthyroid Ophthalmopathies
Fondation Ophtalmologique Adolphe de Rothschild 294
Large-scale testing (Phase 3)Study completedNCT02155049
What this trial is testing

Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues

Who this might be right for
Thyroid Associated Ophthalmopathies
Rabin Medical Center 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT03098225
What this trial is testing

A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
University of Pisa 120
Testing effectiveness (Phase 2)UnknownNCT04876534
What this trial is testing

Tocilizumab in Active Moderate-severe Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 64
Large-scale testing (Phase 3)Active Not RecruitingNCT05517447
What this trial is testing

Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Immunovant Sciences GmbH 180
Large-scale testing (Phase 3)Study completedNCT03461211
What this trial is testing

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

Who this might be right for
Thyroid Eye Disease
Amgen 51
Not applicableUnknownNCT01280214
What this trial is testing

Local Triamcinolone Injection in Active Thyroid Orbitopathy

Who this might be right for
Thyroid Disease
HaEmek Medical Center, Israel 30
Large-scale testing (Phase 3)Looking for participantsNCT06112340
What this trial is testing

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 75
Not applicableStudy completedNCT07471997
What this trial is testing

Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TED
Instituto de Oftalmología Fundación Conde de Valenciana 15
Not applicableStudy completedNCT05713097
What this trial is testing

TSI and Its Relationship With Graves' Disease Relapse

Who this might be right for
Graves DiseaseImmunoglobulinAnti-Thyroid Antibodies Disorder
University of Medicine and Pharmacy at Ho Chi Minh City 352
Not applicableEnrolling By InvitationNCT07332988
What this trial is testing

Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients With Graves Disease

Who this might be right for
Dry Eye Disease (DED)Graves Ophthalmopathy
Grigore T. Popa University of Medicine and Pharmacy 30
Not applicableUnknownNCT00174057
What this trial is testing

The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves'Ophthalmopathy

Who this might be right for
Graves' Ophthalmopathy
National Taiwan University Hospital 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06106828
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Hoffmann-La Roche 127
Post-approval studies (Phase 4)Study completedNCT01458600
What this trial is testing

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

Who this might be right for
Graves´ Disease
Mikael Lantz 65
Post-approval studies (Phase 4)WithdrawnNCT01272414
What this trial is testing

Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction

Who this might be right for
Graves Ophthalmopathy
University of Toronto
Testing effectiveness (Phase 2)Study completedNCT06525506
What this trial is testing

IBI311 in Subjects With Inactive or Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Innovent Biologics (Suzhou) Co. Ltd. 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT07308964
What this trial is testing

Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseThyroid Eye Disease, TEDThyroid Eye Disease (TED)
Sheba Medical Center 40
Not applicableStudy completedNCT01408368
What this trial is testing

Subtotal Versus Total Thyroidectomy for Graves' Disease

Who this might be right for
ThyroidGoiter
Jagiellonian University 200
Testing effectiveness (Phase 2)Study completedNCT00424151
What this trial is testing

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

Who this might be right for
Graves' Dysthyroid OphthalmopathyThyroid Related Orbitopathy
Silkiss, Rona Z., M.D., FACS 12
Post-approval studies (Phase 4)Looking for participantsNCT07152392
What this trial is testing

Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 50
Load More Results